Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal DNA and RNA synthesis is not a single molecular target or receptor but a general phrase describing the processes through which fungal organisms duplicate and express their genetic material. It encompasses a broad range of essential enzymes and pathways, including DNA polymerases, RNA polymerases, RNA interference (RNAi) machinery (comprising Dicer, Argonaute, and RNA-dependent RNA polymerase), and other proteins involved in nucleic acid metabolism. These pathways are crucial for gene regulation, genome defense, and cellular adaptation in fungi[1][2][4]. Therapeutic agents such as flucytosine exploit this process by converting to toxic nucleotide analogs that inhibit DNA or RNA synthesis in fungal cells. However, referencing "Fungal DNA and RNA synthesis" as a specific target is incorrect, as it does not refer to a single, well-defined molecule or receptor but rather to an entire class of fundamental biochemical processes[1][2][4].
Inhibition of nucleic acid synthesis (by interfering with DNA and/or RNA production enzymes, e.g., via conversion to 5-fluorouracil in the case of flucytosine)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal DNA and RNA synthesis.